Respondent’s role in SCP use (n = 394) |
|
Identify survivors who are eligible to receive SCPs |
72.3 |
Develop SCPs |
66.0 |
Create and/or revise SCP templates |
62.7 |
Save SCPs |
53.6 |
Deliver SCPs to cancer survivors |
53.6 |
Deliver SCPs to survivors’ follow-up care providers |
48.2 |
Update SCPs |
36.5 |
Refer survivors to receive SCPs |
28.4 |
None of the above |
0.0 |
Respondent’s current position (n = 394) |
|
Nurse Navigator |
44.2 |
Registered Nurse |
29.9 |
Oncology Nurse Practitioner |
9.6 |
Cancer registry staff |
3.8 |
Patient Navigator (not a nurse or social worker) |
3.3 |
Social Worker |
3.3 |
Nurse Practitioner (not oncology-based) |
2.8 |
Health Educator |
2.0 |
Oncologist (physician) |
1.5 |
Physician other than oncologist |
1.5 |
Oncology Physician Assistant |
1.3 |
Physician Assistant (not oncology-based) |
0.8 |
Medical Director |
0.0 |
Other |
22.1 |
Decline to respond |
1.3 |
Annual incident cancers [median (range)] (n = 292) |
700 (1-8000) |
Cancer program type (n = 292) |
|
Community hospital comprehensive |
45.5 |
Community hospital |
27.4 |
Affiliate |
12.7 |
Hospital associate |
11.3 |
Teaching hospital |
10.6 |
Freestanding |
7.9 |
National Cancer Institute-designated comprehensive |
5.5 |
National Cancer Institute-designated |
4.1 |
Integrated |
2.7 |
Network |
2.1 |
Pediatric |
1.7 |
National Cancer Institute-designated cancer network |
1.4 |
Veterans Affairs |
1.4 |
Pediatric cancer program component |
0.7 |
Don’t know |
1.7 |
Decline to respond |
0.7 |
Organization Membership (n = 292) |
|
American College of Surgeons Commission on Cancer |
80.8 |
Association of Community Cancer Centers |
38.4 |
American Society for Clinical Oncology Quality Oncology Practice Initiative |
36.3 |
National Comprehensive Cancer Network |
26.0 |
NCI Community Cancer Centers Program |
5.8 |
LIVESTRONG Foundation (formerly Lance Armstrong Foundation) |
3.8 |
National Coalition for Cancer Survivorship |
3.1 |
Don’t know |
12.0 |
Decline to respond |
2.4 |
Tumor groups for which SCPs are used (n = 394) |
|
Breast |
85.0 |
Colon or rectal (including anal) |
58.6 |
Lung |
53.3 |
Prostate |
43.4 |
Head and neck |
42.1 |
Endometrial |
32.2 |
Ovarian |
31.2 |
Lymphoma (Hodgkin and non-Hodgkin) |
31.0 |
Testicular |
25.1 |
Kidney |
24.1 |
Melanoma |
23.9 |
Thyroid |
20.1 |
Brain |
18.5 |
Myeloma |
14.0 |
Leukemia |
12.2 |
Clinical trials patients |
6.6 |
Other |
7.6 |
Don’t know |
1.0 |
Decline to respond |
1.3 |
Organizational system for identifying survivors (n = 257) |
|
Non-automated system |
45.9 |
No system |
44.4 |
Automated system |
4.7 |
Other |
12.5 |
Decline to respond |
0.8 |
Process for determining eligibility (n = 257) |
|
On a case-by-case basis |
73.2 |
Patient receives care in a particular tumor group |
23.0 |
Other |
21.0 |
Don’t know |
0.4 |
Decline to respond |
0.8 |